VEMLIDY
Identification of Vemlidy
| No description |
Google image searchProduct monograph
Active ingredient
tenofovir alafenamide (tenofovir alafenamide hemifumarate), 25 MG
DIN: 02464241
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: GILEAD SCIENCES CANADA INC
Date: 20-JUN-2017
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AF — Nucleoside and nucleotide reverse transcriptase inhibitors (ATC, ATC/DDD)
- J05AF13 — TENOFOVIR ALAFENAMIDE (ATC/DDD)
Reference brand drug: Vemlidy
